Blastic Variant of Mantle Cell Lymphoma

 

Blastic variant of mantle cell lymphoma
Mantle cell leukemia (blastic variant): Peripheral blood smear, Wright-Giemsa stain, 1000x

Description:

In this aggressive variant of mantle cell lymphoma/leukemia the blasts resemble L2 ALLs in size. The cytoplasm is variable in amount and grey to blue-grey in color. The nuclear appearance is variable with frequent clefts present. The nuclear chromatin is immature and evenly dispersed with variable clumping, and nucleoli are usually visible.

Immunophenotype:

C19+, C5+, FMC 7+, Cyclin D1+, sIg+ (with IgM and IgD), and CD23-.

Cytogenetics:

The gold standard is the finding of the t (11;14).

Prognosis:

Very aggressive and usually resistant to therapy. Prognosis poor.

General References:

  • Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. Vol. 3 of World Health Organization classification of tumors. Lyon, France: IARC Press, 2001

 

For all publication requests, please complete the image permission form and we will respond to your request shortly. 

[return to list
Charles  E.  Hess,  M.D.,FACP
Professor of Internal Medicine
Department of Medicine
Division of Hematology/Oncology

  M.D. Degree: University of Virginia, 1959
  Residency: Internal Medicine, University of Virginia
  Fellowship: Hematology, University of Virginia
  Certification: Internal Medicine
Hematology
  Research Interests: Hematologic malignancies, splenomegaly
  Department Web Site: http://www.healthsystem.vir
ginia.edu/internet/internal/
  Phone: (434) 924-2572